Outcome of Board Meeting

Makers Laboratories Ltd. Regd. Office : 54-D, Kandivali Indl. Estate, Kandivali (West), Mumbai - 400 067. CIN: L24230MH1984PLC033389, website: www.makerslabs.com, e-mail: makers@makerslabs.com THRU ONLINE FILING August 7, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023. Dear Sir, Re : Outcome of Board Meeting 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith our Unaudited Standalone and Consolidated Financial Results along with the limited review report of the Company’s Auditors thereon for the 1st Quarter ended 30th June, 2026, which was taken on record at the Meeting of the Board of Directors of the Company held today at Kandivli, Mumbai. 2. The Board also noted that the term of appointment of Mr. Saahil Parikh (DIN 00400079) as the Whole-time Director/CEO of the Company is coming to an end on 10th August, 2026 and that Mr. Saahil Parikh has informed the Board that he does not wish to be re-appointed as the Whole-time Director/CEO of the Company, due to personal and professional reasons. He has confirmed that there are no other material reasons for this decision. However, since he has agreed to continue as the Non-Executive Director, the Board has appointed him as the Non-Executive, Non-Independent Director of the Company w.e.f 11th August, 2026, subject to the approval of the shareholders of the Company. Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the change in the Directorship of Mr. Saahil Parikh: Name : Mr. Saahil Parikh (DIN 00400079) 1. Reason for Change Appointed as the Non-Executive, Non- Independent Director w.e.f. 11th August, 2026 upon completion of his term of appointment as the Whole-time Director/CEO of the Company on 10th August, 2026, subject to the approval of the Shareholders. 2. Date of appointment & term Liable to retire by rotation as a Director. of appointment Tel.No. : 022 - 68572800 , Fax No. : 022 - 28688544 Makers Laboratories Ltd. Regd. Office : 54-D, Kandivali Indl. Estate, Kandivali (West), Mumbai - 400 067. CIN: L24230MH1984PLC033389, website: www.makerslabs.com, e-mail: makers@makerslabs.com 3. Brief Profile (in case of Mr. Saahil Parikh aged 51 years has done his appointment) graduation in Bio-Chemistry from Gujarat University. He has also done Diploma in Management Studies from Ahmedabad Management Association. He has about 25 years of experience in the pharma industry in the field of pharma production, quality control, pharma projects and general management. 4. Disclosure of relationships Not related to any Director or Key Managerial between directors Personnel of the Company. He is not debarred from holding the office of the Directorship by virtue of order passed by SEBI or by any other competent authority. 3. With this change in this Directorship, the revised composition of the Board of Directors of the Company w.e.f. 11th August, 2026 shall be as under : Mr. R. K. P. Verma Chairman, Independent Director Ms. Dipti Shah Independent Director Mr. Vishal Jain Independent Director Mr. Prashant Godha Non-Executive, Non-Independent Director Mr. Saahil Parikh Non-Executive, Non-Independent Director Mr. Nilesh Jain Executive, Whole-time Director We confirm that none of the Directors of the Company are debarred from holding the office of the Directorship by virtue of order passed by SEBI or by any other competent authority. 4. Due to the above changes in the Directorship, the following Committees of the Board is re-constituted as under : Stakeholders Relationship Mr. R. K. P. Verma Chairman of the Committee / Committee Independent Director Mr. Vishal Jain Independent Director Mr. Saahil Parikh Director Risk Management Mr. Saahil Parikh Director Committee Mr. Nilesh Jain Executive, Whole-time Director Mr. Sandeep Sr. Manager (Accounts) / CFO Kadam Kindly note the meeting started at 11.00 a.m. and concluded at 11.55 a.m. Thanking you. Yours faithfully For Makers Laboratories Limited Piyush Ajmera, Company Secretary (ACS 58712) Tel.No. : 022 - 68572800 , Fax No. : 022 - 28688544 MakersLaboratoriesLimited Regd.Office:54D,KandivliIndustrialEstate,Kandivli(W),Mumbai400067 CIN:L24230MH1984PLC033389 Tel:+912228688544E-mail:investors@makerslabs.com,Website:www.makerslabs.com STATEMENTOFUNAUDITEDSTANDALONEFINANCIALRESULTSFORTHEQUARTERENDEDJUNE30,2026 (AllFiguresareRupeesinLacsunlessotherwisestated) Particulars QuarterEnded YearEnded 30.06.2026 31.03.2026 30.06.2025 31.03.2026 Unaudited Unaudited Unaudited Audited Revenue from Operations 1,018.75 1,127.46 1,372.68 5,034.73 Total Income (I + II) 1,025.90 1,129.92 1,376.58 5,094.01 IV Expenses^ a) Cost of materials consumed _____ 141.84 99.60 161.22 546.49 b) Purchases of stock-in-trade __ 546.96 571.84 702.96 2220.36 c) Changes in inventories of finished goods, (241.24) (72.14) (146.47) (165.00) work-in-progressandstock-in-trade f) Depreciation and amortisation expense____ 69.41 69.20 69.89 280.40 Total Expenses (IV) ______ ___ 1,151.62 1,246.04 1,406.53 5,295.14 V Profit/(Loss)BeforeexceptionalitemsandTax (125.72) (116.12) (29.95) (201.13) (III-IV) VI Exceptional Items income/ (expenses) VII Profit/ (Loss) Before Tax (V+VI) _________ (125.72) (116.12) j29.95) (201.13) VIII Tax Expense CurrentTax Short/ExcessProvisionofearlieryears Deferred Tax (Asset) / Liability____________ (18.22) (19-75) (2.75) (29.15) IX Profit/(Loss )forthe period fromContinuing (107.50) (96.37) (27.20) (171.98) OtherComprehensiveIncome Itemsthatwillnotbereclassifiedsubsequentlyto (b)FairValuechangethroughOther 0.96 1.75 (1.08) 0.95 Tax Effect thereon (0-14) (0-25) (0-21) (0-50) X OtherC om pre hensiveIncome/(Loss)forthe 2.67 11.40 (2.18) 7.85 period,netoftax XI Total Comprehensive Income after tax (IX + X) (104.83) (84.97) (29.38) (164.13) Paid-up equity share capital (Face value of Rs.10/- 590.04 590.04 590.04 590.04 Earningspershare(ofRs.10/-each)-Not annualised: Basic & Diluted (1-82) (1-63) (0.46) (2-91) Notes: 1 The above unaudited financial results as reviewed by the Audit Committee, were approved and taken on record by the Board of Directors in their meeting held on August 07, 2026. 2 The Statutory Auditors have carried out Limited Review of the aforesaid results and have issued their unmodified report thereon. 3 The above standalone unaudited financial results are prepared in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013 and are in compliance with the presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as Amended). 4 The Company has only one reportable segment viz.'Pharmaceuticals' and as such there are no separate reportable segment as per Indian Accounting Standard "Operating Segment (Ind AS-108)" 5 The figures of the quarter ended March 31, 2026 are the balancing figures between the figures for the audited full financial year and year to date unaudited figures up to the third quarter of the respective financial years which were subjected to limited review by the statutory auditors. 6 Figures of the previous period have been regrouped to confirm to the figures of the current period's classification wherever necessary. By Order of the Board For Makers Laboratories Limited -'Saahil Parikh Place : Mumbai, Wholetime Director & CEO Date : August 07,2026 (DIN 00400079) N V C & Associates LLP CharteredAccountants 903-904,9th Floor, Raheja Chambers, 213, Nariman Point, Mumbai 400 021. Tel.: (91-22) 6752 7100 Email: nvc@nvc.in LLPIN -ACM-9656 Independent Auditor's Review Report on Unaudited Standalone Financial Results of Makers Laboratories Limited for the quarter ended June 30, 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 (as Amended) The Board of Directors of Makers Labor [Showing first 8,000 characters — download PDF for full document]